XPRIZE Healthspan Investor Summit

In collaboration with:

Welcome to the application process for the XPRIZE Healthspan Investor Summit.

XPRIZE Healthspan is a 7-year, $101 million global competition to revolutionize the way we approach human aging.

The XPRIZE Healthspan Investor Summit

XPRIZE Healthspan will be hosting its 2025 Investor Summit in New York City on May 13th, 2025.

Hosted in exclusive collaboration with Longevity Investors, this is an invite-only event bringing together the Semifinalist teams from the $101M XPRIZE Healthspan competition and the Finalist teams from the $10M FSHD Bonus Prize, alongside leading investors in healthspan and longevity.

This is a unique opportunity for funders to gain early access to investment opportunities with some of the world’s leading innovators competing in XPRIZE Healthspan.

WHEN & WHERE

May 13, 2025

8:00 AM - 7:00 PM (ET)

CURE Life Sciences, 345 Park Ave S, New York, NY 10010

APPLICATION SUBMISSION

You are invited to fill out the form below and apply for your seat if you are an INVESTOR.

By submitting the application, you show a firm commitment to attend the XPRIZE Healthspan Investor Summit.

SCREENING PROCESS

To ensure a top-quality level of attendees, we conduct a thorough screening process for each individual application.

Once we have reviewed your application and it aligns with our criteria, you will receive a confirmation email.

CRITERIA TO GET ACCEPTED

Applicants will be considered if the following criteria are met:

Have an interest in or track record of funding longevity, biotech, or life sciences startups.
Are actively funding early-stage startups/companies (Seed to Series A).
Have an interest in international companies.
Bring industry expertise, mentorship, or strategic partnerships (e.g., connections to pharma, biotech, regulatory advisors).
Align with XPRIZE’s mission of accelerating scientific breakthroughs for societal benefit and impact.

More details

Application Form

*By applying, you consent to receiving newsletters from Longevity Investors and Longevity Investors News